JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 Event rates with enoxaparin with or without glycoprotein IIb/IIIa inhibitors in the NICE trials. MI = myocardial infarction; NICE = National Investigators Collaborating on Enoxaparin; TVUR = target vessel urgent revascularization. Kereiakes DJ, Grines C, Fry E. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invas Cardiol 2001;13:272–8. Printed with permission from HMP Communications, 2002. Reprinted with permission from the American College of Cardiology Foundation, J Am Coll Cardiol 2001;37 Suppl A:1A–648A; Abstract 1253–97.





Right arrow Return to article


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK